Hakiman e Shargh Research

Hakiman-e Shargh Research (HSR) is a prominent Iranian Contract Research Organization (CRO) that provides a wide range of clinical research services to the pharmaceutical and biotechnology industries. The company specializes in conducting Phase I through IV clinical trials, with a particular emphasis on bioequivalence and bioavailability studies for generic drugs and biosimilars. HSR offers comprehensive support throughout the drug development lifecycle, including protocol design, regulatory affairs, data management, and pharmacovigilance. Equipped with advanced bioanalytical laboratories, the organization ensures compliance with international Good Clinical Practice (GCP) and Good Laboratory Practice (GLP) standards. By collaborating with medical universities and healthcare institutions, HSR facilitates the clinical validation of therapeutic products within the Middle Eastern market.